Opinion

Video

Step Approach for FM Treatment

Experts discuss their step therapy approaches for the treatment of fibromyalgia (FM).

Transcript

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP: I know Dr Natelson gave us his step approach as to how he starts these different agents. Do either of you two have any thoughts about what is that kind of step approach? What do you use to start patients on these agents?

Kostas Botsoglou, MD: I typically start with the anticonvulsants. Gabapentin primarily try to titrate up to a to a level at least up to three times a day then I'll introduce duloxetine thereafter whether in combination or as monotherapy. But then I really try to avoid going to the opioids and going to the more controlled substances after that. That's where I'll refer them out to perhaps a pain specialist.

Benjamin Natelson, MD: Have either of you ever tried mexiletine?

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP: No. I've seen that with some of my headache patients who have gone to tertiary centers but my chronic daily folks, but I have not used it for this. What about you, Dr Clauw?

Daniel Clauw, MD: It depends on a neurologist so he's comfortable using these drugs but none of these have been tested in fibromyalgia and they're widely used by neurologists that treat neuropathic pain and things like that but they're not most of us don't think of using these drugs. I'm not saying that they don't work. I'm saying we don't know that they do work. There are no trials showing that they work in conditions like fibromyalgia.

Benjamin Natelson, MD: He's right. But when I have a desperate patient, if I can try something rather than opioids, I'll try something and then ultimately, I will go to the opioids. I understand your hesitation and I understand Dan, but if someone is bedridden with horrible pain I just I won't ignore it. I'll try it. And if the opioids don't work, then we taper them off.

Transcript edited for clarity.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.